Overview

Special Survey for Paediatric Subjects

Status:
Completed

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

Summary

This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using NovoRapid® (insulin aspart) in children with type 1 and type 2 diabetes under normal clinical practice conditions.

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Insulin
Insulin Aspart